Printer Friendly

Breakout Discussion Groups Announced at CHI's Immunogenicity Summit 2012 in Bethesda, MD, Oct. 10-12.

Needham, MA, September 11, 2012 --(PR.com)-- Cambridge Healthtech Institute (CHI) today announced details of ten breakout discussion groups, each to be hosted by a different moderator, at its fourth annual Immunogenicity Summit 2012 to be held on October 10-12, 2012 at the DoubleTree by Hilton Hotel in Bethesda, MD. Approximately 300 delegates from over 50 organizations will attend. This 2-part event will cover developments in assay technologies, risk assessment, regulatory guidance and means of predicting and avoiding immunogenicity.

Breakout Discussions Part One, Wednesday October 10:

Table 1: Challenges in Developing Neutralizing Antibody Assays

Moderator: Deborah Finco, Ph.D., Senior Principal Scientist, Immunotoxicology COE, Pfizer, Inc.

Table 2: Dealing with Pre-existing Positive ADA Activity in Study Patients

Moderator: Jim McNally, Ph.D., Senior Principal Scientist, Pfizer, Inc.

Table 3: Practical Application of Immunogenicity Pre-Clinical Risk Assessment

Moderator: Paul Chamberlain, NDA Advisory Board

Table 4: Detection of Immune Complexes and Their Impact on Immunogenicity Assessment

Moderator: Steve J. Swanson, Ph.D., Executive Director, Medical Sciences, Clinical Immunology, Amgen, Inc.

Table 5: Immunogenicity Testing During Clinical Trials

Moderator: Frank F. Weichold, M.D., Ph.D., Director, Clinical Pharmacology and DMPK, Translational Science, MedImmune, LLC

Table 6: IgE Anti-drug Assay Development and Validation

Jorgen Dahlstrom, Ph.D., MBA, Scientific Director, ImmunoDiagnostics, Thermo Fisher Scientific

Breakout Discussions Part Two, Friday October 12:

Table 1: Product-related Factors that Contribute to Immunogenicity

Moderator: Wim Jiskoot, Ph.D., Professor, Division of Drug Delivery Technology, Leiden University

Table 2: To what Extent can Immunogenicity Prediction affect the Clinical Strategy?

Moderator: Timothy Hickling, Ph.D., Associate Research Fellow, PDM Immunogenicity Sciences, Pfizer, Inc.

Table 3: Immune Tolerance Approaches

Moderator: Amy Rosenberg, M.D., Director, Therapeutic Proteins, CDER/FDA

Table 4: Relevance of Animal Models for Predicting the Immunogenicity of Therapeutic Proteins

Jack Ragheb, M.D., Ph.D., Principal Investigator, Immunology, Therapeutic Proteins, CDER/FDA

Delegates attending the Immunogenicity Summit 2012 may track-hop to the sessions at CHI's concurrent event, PK/PD of Novel Constructs: Bispecific Antibodies, Antibody Fragments, and ADCs.

To inquire about sponsoring and/or exhibiting, contact Tim McLucas, 781-972-1342, tmclucas@healthtech.com.

Writers and editors are encouraged to attend. To request a press pass, contact Lisa Scimemi at lscimemi@healthtech.com.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:

James Prudhomme

Cambridge Healthtech Institute

781-972-5400

jprudhomme@healthtech.com

Contact Information:

Cambridge Healthtech Institute

James Prudhomme

781-972-5400

Contact via Email

www.chicorporate.com
COPYRIGHT 2012 PR.com
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR.com (Press Releases)
Geographic Code:4EUUK
Date:Sep 11, 2012
Words:510
Previous Article:Daily Yoga V2.0 Now Available on Google Play for Android Users.
Next Article:Black and Missing Foundation Inc to Launch "Ask BAM FI" Advice Segment.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters